CONMED Corporation (NASDAQ:CNMD) issued its earnings results on Thursday. The medical technology company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.01, Bloomberg Earnings reports. The business had revenue of $190.10 million during the quarter, compared to analysts’ expectations of $187.13 million. CONMED Corporation had a net margin of 1.99% and a return on equity of 8.43%. The business’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.41 earnings per share. CONMED Corporation updated its FY17 guidance to $1.85-1.90 EPS.
CONMED Corporation (NASDAQ:CNMD) opened at $53.37 on Friday. The company has a current ratio of 2.62, a quick ratio of 1.57 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of 30.41, a P/E/G ratio of 3.35 and a beta of 0.66.
The company also recently declared a quarterly dividend, which was paid on Thursday, October 5th. Shareholders of record on Friday, September 15th were given a $0.20 dividend. The ex-dividend date was Thursday, September 14th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.50%. CONMED Corporation’s payout ratio is currently 142.86%.
Several research analysts have recently weighed in on the stock. KeyCorp reissued a “hold” rating on shares of CONMED Corporation in a report on Friday. BidaskClub cut shares of CONMED Corporation from a “sell” rating to a “strong sell” rating in a report on Saturday, August 5th. Zacks Investment Research raised shares of CONMED Corporation from a “sell” rating to a “hold” rating in a report on Tuesday. Piper Jaffray Companies reissued a “hold” rating and set a $46.00 price objective on shares of CONMED Corporation in a report on Friday. Finally, TheStreet raised shares of CONMED Corporation from a “c+” rating to a “b-” rating in a report on Thursday, August 3rd. One analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $50.33.
In other news, Director Jo Ann Golden sold 3,000 shares of the stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $50.00, for a total value of $150,000.00. Following the completion of the transaction, the director now directly owns 19,782 shares of the company’s stock, valued at approximately $989,100. The sale was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.62% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “CONMED Corporation (CNMD) Announces Quarterly Earnings Results” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/11/04/conmed-corporation-cnmd-announces-quarterly-earnings-results.html.
About CONMED Corporation
CONMED Corporation is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.
What are top analysts saying about CONMED Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CONMED Corporation and related companies.